REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Medifarma Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Medifarma Sas Profile Updated: June 20, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorios Medifarma Sas is based in Colombia, with the head office in Bogota D.C.. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was established on November 21, 2012. In 2022, the company reported a net sales revenue increase of 35.93%. Its total assets decreased by 66.24% over the same period. The net profit margin of Laboratorios Medifarma Sas decreased by 64.87% in 2022.

Headquarters
Cl 141 9 40 Of 101
Bogota D.C.; Bogota D.C; Postal Code: 1005

Contact Details: Purchase the Laboratorios Medifarma Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Laboratorios Medifarma Sas report to view the information.
Incorporation Date:
November 21, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorios Medifarma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
35.93%
Total operating revenue
62.46%
Operating profit (EBIT)
-104.19%
Net Profit (Loss) for the Period
-104.19%
Total assets
-66.24%
Total equity
163.07%
Operating Profit Margin (ROS)
-64.87%
Net Profit Margin
-64.87%
Return on Equity (ROE)
67.65%
Quick Ratio
23.77%
Cash Ratio
3.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?